Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Planning for Commercial Success | Contract Pharma

What are you searching for?

Sign in
Videos

Planning for Commercial Success

Best Practices for Designing Cell & Gene Therapy Clinical Trails

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cell and gene therapy applications have, in the last three years, made the jump from pure research products to commercialized products with high clinical efficacy, particularly for hematologic malignancies. In order to facilitate further development of cell and gene therapies for other diseases, such as solid cancers and inherited diseases, it will be important to define a framework for such undertakings, and choose the right path for eventual commercialization of successful products. In this webinar, Siofradh McMahon, Senior Manager, Clinical translation regulatory affairs at CCRM, elaborates on how to design early development programmes and clinical trials for CGTs to ensure that the product can be commercialized successfully in all target markets i.e. can be reimbursed and adopted successfully despite small patient numbers, rare diseases, complex administration etc.

(Presented as part of ISCT Webinar 2019: Planning for Commercial Success – Best Practices for Designing Cell & Gene Therapy Clinical Trials)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters